Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Valvular Heart Disease

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 341 articles: HTML format

Single Articles

June 2026
1. SPANJERSBERG TCF, Hassanzada F, Jongbloed JDH, Dooijes D, et al
   Population and family data support TNNT2 p.Arg288Cys as an intermediate effect variant in hypertrophic cardiomyopathy.
   Int J Cardiol. 2026;452:134264.
   PubMed     Abstract available
   
   
   April 2026
2. ZOCCHI C, Milazzo A, Panichella G, Garofalo M, et al
   Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition.
   Int J Cardiol. 2026;448:134175.
   PubMed     Abstract available
   
   
   
3. BONACCHI G, Del Franco A, Agostoni P, Agricola E, et al
   Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
   Int J Cardiol. 2026;448:134152.
   PubMed     Abstract available
   
   
   
4. LUPU L, Rogers T, Abusnina W, Haberman D, et al
   Coronary access after TAVR with the 4th and 5th -generation self-expanding Evolut valves: The EPROMPT-CA study.
   Int J Cardiol. 2026;448:134073.
   PubMed     Abstract available
   
   
   March 2026
5. HSIAO CS, Hsiao SH, Shiau JW, Chiou KR, et al
   Prognostic impact of systolic pulmonary and aortic regurgitation in heart failure with preserved ejection fraction.
   Int J Cardiol. 2026;454:134436.
   PubMed     Abstract available
   
   
   
6. EL-ANDARI R, Bozso SJ
   Sex differences after valve-in-valve transcatheter aortic valve implantation: The rule or the exception?
   Int J Cardiol. 2026 Mar 18:134433. doi: 10.1016/j.ijcard.2026.134433.
   PubMed    
   
   
   
7. BJERREGAARD L, Maron MS, Jensen MSK, Dybro AM, et al
   Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy.
   Int J Cardiol. 2026;447:134147.
   PubMed     Abstract available
   
   
   
8. MATTA MG, Dababneh E, Camuglia A, Niranjan S, et al
   Sex differences in patient-reported and clinical outcomes after valve-in-valve TAVI: Insights from the Australian ACOR registry.
   Int J Cardiol. 2026;453:134273.
   PubMed     Abstract available
   
   
   February 2026
9. FISHMAN B, Maor E, Ashri S, Loutati R, et al
   The outcome of patients with severe tricuspid regurgitation by body mass index.
   Int J Cardiol. 2026;451:134251.
   PubMed     Abstract available
   
   
   
10. FRUMKIN D, Nersesian G, Spethmann S, Hindricks G, et al
    Acute type A aortic dissection following TAVI.
    Int J Cardiol. 2026;445:134035.
    PubMed     Abstract available
    
    
    
11. SISINNI A, Barreiro-Perez M, Freixa X, Arzamendi D, et al
    TRI.Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repair.
    Int J Cardiol. 2026;445:134021.
    PubMed     Abstract available
    
    
    
12. JIANG J, Sun L, Hong Q, Zhang J, et al
    Comprehensive assesment of right ventricular function in patients with primary mitral regurgitation.
    Int J Cardiol. 2026 Feb 10:134232. doi: 10.1016/j.ijcard.2026.134232.
    PubMed     Abstract available
    
    
    
13. FREIXA-BENAVENTE A, Garrido-Oliver J, Roses-Noguer F, Dux-Santoy L, et al
    Blood speckle imaging for the assessment of aortic valve velocity in healthy children: Reproducibility and comparison with Doppler echocardiography.
    Int J Cardiol. 2026 Feb 4:134223. doi: 10.1016/j.ijcard.2026.134223.
    PubMed     Abstract available
    
    
    
14. SHEASHAA H, Farina JM, Scalia IG, Awad K, et al
    Diagnostic performance of aortic valve calcium scoring for severe aortic stenosis in patients with chronic kidney disease.
    Int J Cardiol. 2026 Feb 3:134217. doi: 10.1016/j.ijcard.2026.134217.
    PubMed     Abstract available
    
    
    
15. POLIZZI R, Canciello G, Ordine L, di Napoli S, et al
    Reverse septal curvature in hypertrophic cardiomyopathy: Implications for function, structure and arrhythmic risk.
    Int J Cardiol. 2026;444:134013.
    PubMed     Abstract available
    
    
    
16. BONANNI F, Ballerini A, Gozzini A, Marchi A, et al
    Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63.
    Int J Cardiol. 2026;444:134010.
    PubMed     Abstract available
    
    
    
17. SAKUL S, DiazSaravia S, Berman B, Dominguez AC, et al
    "Echo-derived estimate of peak left atrial pressure in patients with iatrogenic atrial septal defects following transcatheter mitral edge-to-edge repair".
    Int J Cardiol. 2026;444:133975.
    PubMed     Abstract available
    
    
    January 2026
18. CANTONE A, Serenelli M, Porcari A
    Beyond the valve: The long shadow of transthyretin amyloidosis in aortic stenosis.
    Int J Cardiol. 2026;449:134196.
    PubMed    
    
    
    
19. KHAN S, Balasubramanian A, Lim B, Demir O, et al
    PREDICT - patient referral evaluation to determine indication for computed tomography to identify small aortic annulus size in patients with severe aortic stenosis.
    Int J Cardiol. 2026 Jan 12:134177. doi: 10.1016/j.ijcard.2026.134177.
    PubMed     Abstract available
    
    
    
20. PATEL KP, Autherith M, Scully PR, Koschutnik M, et al
    Long-term outcomes in patients with aortic stenosis and transthyretin cardiac amyloidosis.
    Int J Cardiol. 2026 Jan 8:134135. doi: 10.1016/j.ijcard.2025.134135.
    PubMed     Abstract available
    
    
    
21. GAROFALO M, Scheggi V, Bohbot Y, Hasan J, et al
    Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR.
    Int J Cardiol. 2026;442:133915.
    PubMed     Abstract available
    
    
    
22. TALMOR-BARKAN Y, Levi A, Barbanti M, Valvo R, et al
    The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI.
    Int J Cardiol. 2026;442:133916.
    PubMed     Abstract available
    
    
    
23. VESELKA J, Liebregts M, Cooper R, Faber L, et al
    Impact of centre experience on complete clinical and haemodynamic response after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2026;442:133865.
    PubMed     Abstract available
    
    
    
24. NAGY V, Racz G, Takacs H, Boda K, et al
    Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;442:133882.
    PubMed     Abstract available
    
    
    December 2025
25. KHEIFETS M, Levi A, Dvir GM, Belkin D, et al
    Transcatheter aortic valve replacement in patients with cancer: A 10-year registry analysis of early and long-term mortality outcomes.
    Int J Cardiol. 2025 Dec 31:134137. doi: 10.1016/j.ijcard.2025.134137.
    PubMed     Abstract available
    
    
    
26. GOLDENBERG GR, Barsheshet A, Erez A, Tal S, et al
    Predictors and outcomes of high ventricular pacing burden post transcatheter aortic valve replacement: 5 years of follow-up.
    Int J Cardiol. 2025;447:134138.
    PubMed     Abstract available
    
    
    
27. GRANOT YN, Bienstock SW, Karlsberg D, Tang GHL, et al
    Correcting CT-derived aortic valve area for LVOT ellipticity: A novel approach.
    Int J Cardiol. 2025 Dec 28:134122. doi: 10.1016/j.ijcard.2025.134122.
    PubMed     Abstract available
    
    
    
28. OBI O, Ayesha A, Lajczak P, Hageen AW, et al
    Sutureless versus transcatheter aortic valve replacement in patients with aortic stenosis: An updated meta-analysis of short- and mid-term outcomes with trial sequential analysis.
    Int J Cardiol. 2025;447:134116.
    PubMed     Abstract available
    
    
    
29. CORCIONE N, Giordano S, Ferraro P, Morello A, et al
    Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study.
    Int J Cardiol. 2025;446:134093.
    PubMed     Abstract available
    
    
    
30. HOROWITZ H, Amsalem I, Carasso S, Postell YY, et al
    Atrial fibrillation and clinical outcomes after mitral transcatheter edge-to-edge repair: A mechanism-stratified cohort study.
    Int J Cardiol. 2025;446:134095.
    PubMed     Abstract available
    
    
    
31. HUA L, Pang S, Zhang Z, Chen J, et al
    Long-term outcomes of tricuspid valve plasty vs. replacement after cardiac surgery: Mortality, reoperation, and anticoagulation complications in patients with postoperative tricuspid regurgitation.
    Int J Cardiol. 2025;445:134080.
    PubMed     Abstract available
    
    
    
32. ZUIN M, Balla C, Canovi L, Serenelli M, et al
    Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;440:133680.
    PubMed     Abstract available
    
    
    
33. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
    Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025;440:133699.
    PubMed    
    
    
    
34. PANG X, Zhao S, Zhang F
    Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
    Int J Cardiol. 2025;440:133698.
    PubMed    
    
    
    November 2025
35. AMIR R, Ladouceur M, Danford D, Aboulhosn J, et al
    Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle.
    Int J Cardiol. 2025 Nov 25:134055. doi: 10.1016/j.ijcard.2025.134055.
    PubMed     Abstract available
    
    
    
36. CARRION-SANCHEZ I, Monteagudo-Ruiz JM, Ramos-Cano P, Martinez-Vives P, et al
    Prognostic significance of cardiovascular magnetic resonance advanced atrial parameters in chronic significant aortic regurgitation.
    Int J Cardiol. 2025;445:134028.
    PubMed     Abstract available
    
    
    
37. SHATANOF R, Ghay S, Fernandez R, Elajami TK, et al
    Cardiac morphologic and functional characteristics in patients with left ventricular excessive Trabeculation versus apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;439:133650.
    PubMed     Abstract available
    
    
    
38. MONASTYRSKI AV, Garcia VS, Carbajal RP, Munoz JM, et al
    Single perclose escalation technique: A novel approach for vascular closure following Transcatheter Aortic Valve Replacement.
    Int J Cardiol. 2025 Nov 11:134012. doi: 10.1016/j.ijcard.2025.134012.
    PubMed     Abstract available
    
    
    
39. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
    Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025;444:134004.
    PubMed     Abstract available
    
    
    October 2025
40. XIE P, Zhou H, Huang Y, Huang Z, et al
    Left ventricular diastolic function modifies clinical outcomes of mild mitral regurgitation.
    Int J Cardiol. 2025 Oct 31:133998. doi: 10.1016/j.ijcard.2025.133998.
    PubMed     Abstract available
    
    
    
41. GONZALEZ-GOMEZ A, Monteagudo Ruiz JM, Arteagoitia Bolumburu A, Mahia P, et al
    The 4A classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study.
    Int J Cardiol. 2025;444:133977.
    PubMed     Abstract available
    
    
    
42. SCHOONVELDE SAC, Nollet EE, Zwetsloot PP, Knackstedt C, et al
    Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.
    Int J Cardiol. 2025;437:133444.
    PubMed     Abstract available
    
    
    
43. BATOOL SJ, Hasan M
    Comment on "Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification".
    Int J Cardiol. 2025 Oct 7:133966. doi: 10.1016/j.ijcard.2025.133966.
    PubMed    
    
    
    
44. YANG L, Chen X, Fang Y, Chen D, et al
    Rate-adaptive pacing in right-sided heart failure with tricuspid regurgitation: A prospective pilot study.
    Int J Cardiol. 2025 Oct 6:133957. doi: 10.1016/j.ijcard.2025.133957.
    PubMed     Abstract available
    
    
    
45. AVIEL G, Hirsh-Raccah B, Idais I, Ghannam RA, et al
    Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression.
    Int J Cardiol. 2025 Oct 4:133931. doi: 10.1016/j.ijcard.2025.133931.
    PubMed     Abstract available
    
    
    
46. ZENG XM, Su Q, Mo LR
    Serum Alpha-1-microglobulin (A1M) and calcific aortic valve stenosis.
    Int J Cardiol. 2025 Oct 2:133953. doi: 10.1016/j.ijcard.2025.133953.
    PubMed    
    
    
    
47. BURTON SM, Nelson M, Rigo G, Caputo M, et al
    Risk factors and clinical impact of transvalvular gradient following surgical repair of degenerative mitral regurgitation.
    Int J Cardiol. 2025 Oct 1:133929. doi: 10.1016/j.ijcard.2025.133929.
    PubMed     Abstract available
    
    
    September 2025
48. HA ET, Phichaphop A, Case BC
    Concomitant coronary artery disease in those undergoing TAVR for severe aortic stenosis: A benign finding?
    Int J Cardiol. 2025 Sep 30:133948. doi: 10.1016/j.ijcard.2025.133948.
    PubMed    
    
    
    
49. ALPERI A, Avanzas P
    SAPIEN 3 in type 0 bicuspid aortic valves: Promising early results.
    Int J Cardiol. 2025;443:133918.
    PubMed    
    
    
    
50. KIRK BH, Palm P, Norgaard MW, Borregaard B, et al
    Prevention of readmission by intensified follow-up after transcatheter aortic valve implantation: Feasibility results of the PREMISS randomised controlled trial.
    Int J Cardiol. 2025 Sep 14:133894. doi: 10.1016/j.ijcard.2025.133894.
    PubMed     Abstract available
    
    
    
51. ZAHID MH, Saleem M, Murtaza A
    Letter to the editor: Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Sep 6:133859. doi: 10.1016/j.ijcard.2025.133859.
    PubMed    
    
    
    
52. LUNZE FI, Dusenbery SM, Gauvreau K, Lee JM, et al
    Mid-term ventricular function in patients with tetralogy of Fallot after transcatheter pulmonary valve replacement: Relationship to baseline right ventricular loading conditions.
    Int J Cardiol. 2025;434:133305.
    PubMed     Abstract available
    
    
    August 2025
53. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    PubMed     Abstract available
    
    
    
54. DUAN YN
    Letter to the editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025 Aug 26:133829. doi: 10.1016/j.ijcard.2025.133829.
    PubMed    
    
    
    
55. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to Letter to the Editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Reinterpreting patient characteristics and institutional effects.
    Int J Cardiol. 2025 Aug 26:133830. doi: 10.1016/j.ijcard.2025.133830.
    PubMed    
    
    
    
56. MARGONATO D, Morosato M, Ingallina G, Wang C, et al
    Natural history outcome of moderate tricuspid regurgitation with preserved left-ventricular ejection fraction.
    Int J Cardiol. 2025;442:133826.
    PubMed     Abstract available
    
    
    
57. DONAL E, Rasmeehirun P, Petersen Saadi M
    From bottle to decanter: Revisiting eRVSP accuracy in the five-grade tricuspid regurgitation era.
    Int J Cardiol. 2025 Aug 20:133805. doi: 10.1016/j.ijcard.2025.133805.
    PubMed    
    
    
    
58. MELILLO F, Speziale G
    Mitral valve treatment for mitral valve regurgitation: The past, the present and the future - A challenge for the surgeon and the imager.
    Int J Cardiol. 2025 Aug 19:133784. doi: 10.1016/j.ijcard.2025.133784.
    PubMed    
    
    
    
59. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to letter to editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 19:133808. doi: 10.1016/j.ijcard.2025.133808.
    PubMed    
    
    
    
60. GITTO M, Kim WK, Buono A, Fabris T, et al
    Clinical outcomes in women and men with raphe-type bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2025;441:133792.
    PubMed     Abstract available
    
    
    
61. FENG D, Wang M, Wang J, Liu X, et al
    Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patients.
    Int J Cardiol. 2025;441:133791.
    PubMed     Abstract available
    
    
    
62. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    PubMed     Abstract available
    
    
    
63. ANNALISA P, Andrea P, Monica F, Giuseppe C, et al
    Genereux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation.
    Int J Cardiol. 2025 Aug 12:133770. doi: 10.1016/j.ijcard.2025.133770.
    PubMed     Abstract available
    
    
    
64. TARTAGLIA F, Gitto M, Villaschi A, Calamita G, et al
    Transcatheter therapies for tricuspid regurgitation: A meta-analysis of randomized trials.
    Int J Cardiol. 2025 Aug 11:133777. doi: 10.1016/j.ijcard.2025.133777.
    PubMed     Abstract available
    
    
    
65. YANG T, Wang Y, Zhu G, Liu W, et al
    TRI-PLAN: A deep learning-based automated assessment framework for right heart assessment in transcatheter tricuspid valve replacement planning.
    Int J Cardiol. 2025 Aug 6:133732. doi: 10.1016/j.ijcard.2025.133732.
    PubMed     Abstract available
    
    
    
66. YU C
    Letter to the editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 6:133723. doi: 10.1016/j.ijcard.2025.133723.
    PubMed    
    
    
    
67. MEI Z, Guo C, Yang H, Li J, et al
    Serum Alpha-1-microglobulin (A1M) as an independent predictor of calcific aortic valve stenosis and its diagnostic value.
    Int J Cardiol. 2025;440:133706.
    PubMed     Abstract available
    
    
    
68. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    PubMed     Abstract available
    
    
    
69. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    PubMed    
    
    
    
70. SHI W, Wang M, Niu G, Zhao Z, et al
    Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance.
    Int J Cardiol. 2025;432:133263.
    PubMed     Abstract available
    
    
    
71. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    PubMed    
    
    
    July 2025
72. GHAFFAR MD, Khan MA
    Refining patient selection and outcome assessment in transcatheter edge-to-edge mitral valve repair: Reflections on a Nationwide Danish study.
    Int J Cardiol. 2025;440:133679.
    PubMed    
    
    
    
73. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    PubMed    
    
    
    
74. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    PubMed     Abstract available
    
    
    
75. ROGERS LJ, Dong T, Kota R, Chan J, et al
    Reoperative mitral valve surgery in the UK: 20-year trends and early outcomes.
    Int J Cardiol. 2025 Jul 5:133602. doi: 10.1016/j.ijcard.2025.133602.
    PubMed     Abstract available
    
    
    
76. XU Z, Chen L, Dai X, Lin Z, et al
    Midterm outcomes of thoracoscopic trans-mitral myectomy for hypertrophic obstructive cardiomyopathy: A single-center, observational study.
    Int J Cardiol. 2025;430:133216.
    PubMed     Abstract available
    
    
    June 2025
77. CELEGHIN R, Pilichou K
    Mitral valve prolapse: A clinical puzzle in search of molecular solutions.
    Int J Cardiol. 2025 Jun 30:133563. doi: 10.1016/j.ijcard.2025.133563.
    PubMed    
    
    
    
78. REN CB, van den Dorpel MMP, Geleijnse M, van Mieghem NM, et al
    How accurate is intraprocedural transthoracic echocardiography in assessing aortic regurgitation after transcathether aortic valve implantation? A single center experience.
    Int J Cardiol. 2025;438:133565.
    PubMed     Abstract available
    
    
    
79. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    PubMed    
    
    
    
80. BARILI F, Pollari F, Marin-Cuartas M, Anselmi A, et al
    Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025 Jun 24:133524. doi: 10.1016/j.ijcard.2025.133524.
    PubMed     Abstract available
    
    
    
81. SCHOPS LB, Truong S, Petersen J, Alhakak A, et al
    Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025;438:133552.
    PubMed     Abstract available
    
    
    
82. SCHREURS BA, van Kimmenade RRJ, Eijsvogels TMH
    Reply by Schreurs et al. to letter regarding article: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025 Jun 20:133545. doi: 10.1016/j.ijcard.2025.133545.
    PubMed    
    
    
    
83. IMRAN A, Haider A
    Comment on "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study".
    Int J Cardiol. 2025;438:133534.
    PubMed    
    
    
    
84. AWAD DM
    Bridging the Gap: Addressing the Underuse of Transcatheter Edge-to-Edge Repair in Chinese Patients with Significant Mitral Regurgitation.
    Int J Cardiol. 2025;438:133519.
    PubMed    
    
    
    
85. VESELKA J, Hansvenclova E, Tesarkova KH, Januska J, et al
    Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;429:133145.
    PubMed     Abstract available
    
    
    
86. LORENZATTI A
    Cholesterol and Valvular heart disease: Is Lipoprotein(a) the sole culprit?
    Int J Cardiol. 2025;437:133510.
    PubMed    
    
    
    
87. TREMAMUNNO G, De Santis D, Santangeli C, Bona GG, et al
    Comparative analysis of pre-transcatheter aortic valve implantation CTA protocols: Optimizing radiation dose and contrast volume.
    Int J Cardiol. 2025;437:133514.
    PubMed     Abstract available
    
    
    
88. JARRAR Y, Alomari L, Otabor E, Lam J, et al
    A safer bet for MitraClip: Choosing between single antiplatelet therapy and dual antiplatelet therapy.
    Int J Cardiol. 2025;437:133476.
    PubMed     Abstract available
    
    
    May 2025
89. LORETZ L, Kim WK, de Backer O, Brunner S, et al
    PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement - A multicenter retrospective registry analysis.
    Int J Cardiol. 2025;436:133428.
    PubMed     Abstract available
    
    
    
90. TRUONG S, Fosbol E, Ostergaard L
    Reply to "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective".
    Int J Cardiol. 2025 May 27:133431. doi: 10.1016/j.ijcard.2025.133431.
    PubMed    
    
    
    
91. NONAKA H, Asami M, Horiuchi Y, Tanaka J, et al
    Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry.
    Int J Cardiol. 2025 May 27:133427. doi: 10.1016/j.ijcard.2025.133427.
    PubMed     Abstract available
    
    
    
92. EBRAHIMI S
    Early aortic valve replacement in asymptomatic severe aortic stenosis: A turning point in management.
    Int J Cardiol. 2025;435:133411.
    PubMed    
    
    
    
93. BLACKMAN DJ, Aktaa S, Pickles D, Abdel-Wahab M, et al
    REdo transcatheter aortic VALVE implantation for the management of transcatheter aortic valve failure: Design and rationale of the REVALVE study.
    Int J Cardiol. 2025 May 18:133400. doi: 10.1016/j.ijcard.2025.133400.
    PubMed     Abstract available
    
    
    
94. HASSAN SAU, Huda NU, Maheen M
    Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025;435:133392.
    PubMed    
    
    
    
95. JABRI A, Suri RM, Villablanca P
    Redo or Redon't? Mitral valve reoperation vs. first-time surgery outcomes: A nationwide study.
    Int J Cardiol. 2025;434:133353.
    PubMed    
    
    
    
96. FATH AR, Aglan A, Maron MS, Phillips JS, et al
    Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;426:133082.
    PubMed     Abstract available
    
    
    April 2025
97. CHEN B, Wang C, Li W
    Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation.
    Int J Cardiol. 2025 Apr 29:133325. doi: 10.1016/j.ijcard.2025.133325.
    PubMed     Abstract available
    
    
    
98. SCHREURS BA, van der Sluijs KM, Hopman MTE, Bakker EA, et al
    Physical activity characteristics in adults with bicuspid aortic valve versus age- and sex-matched controls.
    Int J Cardiol. 2025 Apr 29:133330. doi: 10.1016/j.ijcard.2025.133330.
    PubMed     Abstract available
    
    
    
99. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    Reply to: Correction to external evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2025;433:133310.
    PubMed    
    
    
    
100. WEI P, Zhao G, Dong J, Feng S, et al
     Anatomical suitability and clinical outcomes of transcatheter edge-to-edge repair in Chinese patients with significant mitral regurgitation: A real-world echocardiographic study.
     Int J Cardiol. 2025;433:133317.
     PubMed     Abstract available
     
     
     
101. MAYNTZ SP, Davidovski FS
     Improving gender-specific management of aortic stenosis with IMPULSE registry data.
     Int J Cardiol. 2025;433:133293.
     PubMed    
     
     
     
102. SITGES M
     Improving our management of tricuspid regurgitation: present and future opportunities.
     Int J Cardiol. 2025 Apr 18:133288. doi: 10.1016/j.ijcard.2025.133288.
     PubMed    
     
     
     
103. MCDONOUGH RV
     Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).
     Int J Cardiol. 2025;432:133260.
     PubMed    
     
     
     
104. JACQUEMYN X, Sa MP, Marin-Cuartas M, Bax JJ, et al
     Early aortic valve replacement versus conservative management in asymptomatic severe aortic stenosis: Meta-analysis of time-to-event data of randomized controlled trials.
     Int J Cardiol. 2025;432:133269.
     PubMed     Abstract available
     
     
     
105. IFTIKHAR MK, Iftikhar QUA, Baig MMA
     Mitral valve reoperation: Refining risk stratification for better outcomes.
     Int J Cardiol. 2025;431:133239.
     PubMed    
     
     
     
106. JAVED MN, Ahmed U, Eman NU
     Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective.
     Int J Cardiol. 2025;431:133238.
     PubMed    
     
     
     March 2025
107. BLEIZIFFER S, Messika-Zeitoun D, Steeds R, Appleby C, et al
     Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry.
     Int J Cardiol. 2025 Mar 30:133223. doi: 10.1016/j.ijcard.2025.133223.
     PubMed     Abstract available
     
     
     
108. LUO D, Bjornson E, Wang X, Zhang B, et al
     Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.
     Int J Cardiol. 2025 Mar 27:133218. doi: 10.1016/j.ijcard.2025.133218.
     PubMed     Abstract available
     
     
     
109. TRUONG S, Petersen J, Havers-Borgersen E, Schops LB, et al
     Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
     Int J Cardiol. 2025 Mar 18:133175. doi: 10.1016/j.ijcard.2025.133175.
     PubMed     Abstract available
     
     
     
110. CAI Y, Ou M, Li Y, Zhang X, et al
     Parameters of speckle tracking echocardiography in right atrial fibrosis of patients with rheumatic mitral stenosis: Focusing on right atrial stiffness.
     Int J Cardiol. 2025;429:133170.
     PubMed     Abstract available
     
     
     
111. LAI Q, Wei Z, Zhang X, Li Q, et al
     The passability of delivery catheter system during self-expanding transcatheter aortic valve replacement: A CT-based prediction model.
     Int J Cardiol. 2025 Mar 16:133168. doi: 10.1016/j.ijcard.2025.133168.
     PubMed     Abstract available
     
     
     
112. GODINO C, Nemola G, Sisinni A, Margonato D, et al
     Therapeutical approach of tricuspid regurgitation and right heart failure.
     Int J Cardiol. 2025;429:133163.
     PubMed     Abstract available
     
     
     
113. SONAGLIONI A, Nicolosi GL, Lombardo M
     Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
     Int J Cardiol. 2025;429:133141.
     PubMed    
     
     
     
114. AHMED A, Safiriyu I, Kaddoura R, Mohyeldin M, et al
     Outcomes of transcatheter aortic valve implantation in Africa: A systematic review and meta-analysis.
     Int J Cardiol. 2025 Mar 10:133139. doi: 10.1016/j.ijcard.2025.133139.
     PubMed     Abstract available
     
     
     
115. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
     Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
     Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
     PubMed     Abstract available
     
     
     
116. TAKAHARI K, Utsunomiya H, Tohgi K, Hamada A, et al
     Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and adverse outcomes in aortic stenosis with preserved left ventricular ejection fraction.
     Int J Cardiol. 2025 Mar 2:133106. doi: 10.1016/j.ijcard.2025.133106.
     PubMed     Abstract available
     
     
     
117. FERRI LA, Ancona MB, Papageorgiou C, Vella C, et al
     Computed tomography derived predictors of left ventricular obstruction after TAVR.
     Int J Cardiol. 2025;422:132956.
     PubMed     Abstract available
     
     
     
118. KHAN S, Demir O, Mehmood M, Nabi I, et al
     An automated method of streamlining waiting list by clinical risk fast-tracking for patients awaiting TAVR: SWIFT TAVR algorithm.
     Int J Cardiol. 2025;422:132952.
     PubMed     Abstract available
     
     
     
119. SCHOONVELDE SAC, Alexandridis GM, Price LB, Schinkel AFL, et al
     Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
     Int J Cardiol. 2025;422:132951.
     PubMed     Abstract available
     
     
     February 2025
120. AKITA K, Suwa K, Ohno K, Weiner SD, et al
     Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
     Int J Cardiol. 2025;421:132911.
     PubMed     Abstract available
     
     
     
121. GULER A, Erata YE, Demirtola AI, Turkmen I, et al
     The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy.
     Int J Cardiol. 2025;421:132913.
     PubMed     Abstract available
     
     
     
122. ZENG X, Wu H, Wang R, Huang P, et al
     Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort study.
     Int J Cardiol. 2025;421:132864.
     PubMed     Abstract available
     
     
     
123. ABBAS MT, Farina JM, Awad K, Badr A, et al
     The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration.
     Int J Cardiol. 2025;425:133067.
     PubMed     Abstract available
     
     
     
124. KOLIASTASIS L, Kim WK
     Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
     Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063.
     PubMed    
     
     
     January 2025
125. ALNABTI A, Abujalala S, Al-Hijji M, Othman K, et al
     Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) -first report 24/7/2024.
     Int J Cardiol. 2025 Jan 29:133029. doi: 10.1016/j.ijcard.2025.133029.
     PubMed     Abstract available
     
     
     
126. TUSA M, Amicone S
     Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.
     Int J Cardiol. 2025 Jan 25:133007. doi: 10.1016/j.ijcard.2025.133007.
     PubMed    
     
     
     
127. LU T, Zhu C, Cui H, Meng Y, et al
     Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy.
     Int J Cardiol. 2025;419:132705.
     PubMed     Abstract available
     
     
     
128. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
     Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
     Int J Cardiol. 2025;419:132694.
     PubMed     Abstract available
     
     
     
129. ZHANG L, Ding F, Ren Z, Cheng W, et al
     Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
     Int J Cardiol. 2025;419:132627.
     PubMed     Abstract available
     
     
     
130. KIM M, Seo J, Kim IS, Cho S, et al
     Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis.
     Int J Cardiol. 2025 Jan 11:132980. doi: 10.1016/j.ijcard.2025.132980.
     PubMed     Abstract available
     
     
     
131. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
     Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
     Int J Cardiol. 2025;422:132958.
     PubMed     Abstract available
     
     
     December 2024
132. GAMARRA-VALVERDE NN, Masket D, Henry ML, Mares AC, et al
     Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions.
     Int J Cardiol. 2024 Dec 28:132946. doi: 10.1016/j.ijcard.2024.132946.
     PubMed     Abstract available
     
     
     
133. ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
     Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
     Int J Cardiol. 2024;421:132910.
     PubMed     Abstract available
     
     
     
134. MUSHTAQ S, Chiesa M, Novelli V, Sommariva E, et al
     Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;417:132554.
     PubMed     Abstract available
     
     
     
135. HAGEGE A, Puscas T, El Hachmi M, Parodi A, et al
     The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;417:132542.
     PubMed     Abstract available
     
     
     
136. CORCIONE N, Ferraro P, Finizio F, Cimmino M, et al
     Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.
     Int J Cardiol. 2024;421:132874.
     PubMed     Abstract available
     
     
     
137. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
     Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
     Int J Cardiol. 2024;421:132888.
     PubMed     Abstract available
     
     
     
138. ECHARTE-MORALES J, Scotti A, Bonnet G, Torrado J, et al
     Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry.
     Int J Cardiol. 2024;421:132889.
     PubMed     Abstract available
     
     
     
139. SAIJO Y, Okushi Y, Gillinov AM, Pettersson GB, et al
     Sex-related differences in outcomes and prognosis of severe calcific mitral stenosis due to mitral annular calcification: A propensity-score matched cohort study.
     Int J Cardiol. 2024;421:132893.
     PubMed     Abstract available
     
     
     
140. KIM WK, Bleiziffer S
     Are there sex-specific disparities in transcatheter aortic valve implantation?
     Int J Cardiol. 2024;421:132882.
     PubMed    
     
     
     
141. PANG S, Wu J, Ke Y, Wang Q, et al
     Letter to the Editor: Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
     Int J Cardiol. 2024;421:132883.
     PubMed    
     
     
     
142. YAN T, Weng F, Guo C
     miR-124-3p may exert its effects in hypertrophic cardiomyopathy by inhibiting cardiomyocyte apoptosis.
     Int J Cardiol. 2024;416:132470.
     PubMed    
     
     
     November 2024
143. FEZZI S, Pesarini G, Flaim M, Ding D, et al
     Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
     Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
     PubMed     Abstract available
     
     
     
144. HAFIANE A, Pisaturo A, Favari E, Bortnick AE, et al
     Atherosclerosis, calcific aortic valve disease and mitral annular calcification: Same or different?
     Int J Cardiol. 2024 Nov 16:132741. doi: 10.1016/j.ijcard.2024.132741.
     PubMed     Abstract available
     
     
     
145. BERGHMANS S, Eyskens B, Rega F, Moons P, et al
     A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs.
     Int J Cardiol. 2024;415:132476.
     PubMed     Abstract available
     
     
     
146. SANNA GD, Finocchiaro G
     Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
     Int J Cardiol. 2024;415:132373.
     PubMed    
     
     
     
147. BONAVENTURA J, Maron BJ
     Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
     Int J Cardiol. 2024;415:132366.
     PubMed    
     
     
     
148. PEREIRA AR, Al Jaff AAM, Cabezas JM, de Weger A, et al
     Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach.
     Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712.
     PubMed     Abstract available
     
     
     
149. ABRAHAM B, Sous M, Kaldas S, Nakhla M, et al
     Transcaval access for transcatheter aortic valve implantation: A meta-analysis and systematic review.
     Int J Cardiol. 2024 Nov 11:132720. doi: 10.1016/j.ijcard.2024.132720.
     PubMed     Abstract available
     
     
     
150. LIN S, Zhang Y, Wang S, Ding X, et al
     Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Nov 10:132697. doi: 10.1016/j.ijcard.2024.132697.
     PubMed     Abstract available
     
     
     
151. EL MATHARI S, Hopman LHGA, Bouchnaf C, Heidendael JF, et al
     Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification.
     Int J Cardiol. 2024;414:132443.
     PubMed     Abstract available
     
     
     
152. FERNANDEZ A, Niel N, Parma G, Loza G, et al
     Warfarin use is associated with higher aortic bioprosthetic 18F-fluoride PET uptake.
     Int J Cardiol. 2024;414:132394.
     PubMed     Abstract available
     
     
     October 2024
153. YANG Y, Ye Y
     Women: More susceptible to develop unfavorable in-hospital outcomes after transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Oct 22:132678. doi: 10.1016/j.ijcard.2024.132678.
     PubMed    
     
     
     
154. ALPERI A, Avanzas P
     TAVR in tapered raphe-type stenotic bicuspid aortic valves: excellent results in challenging anatomies.
     Int J Cardiol. 2024 Oct 19:132656. doi: 10.1016/j.ijcard.2024.132656.
     PubMed    
     
     
     
155. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
     External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
     Int J Cardiol. 2024 Oct 19:132653. doi: 10.1016/j.ijcard.2024.132653.
     PubMed     Abstract available
     
     
     
156. FIGLIOZZI S, Masci PG, Monti L, Stankowski K, et al
     Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2024;413:132390.
     PubMed     Abstract available
     
     
     
157. KUMAR M, Hu JR, Ali S, Khlidj Y, et al
     Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study.
     Int J Cardiol. 2024;418:132619.
     PubMed     Abstract available
     
     
     
158. TRUONG S, Petersen J, Schmiegelow MDS, Due H, et al
     Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study.
     Int J Cardiol. 2024;418:132608.
     PubMed     Abstract available
     
     
     September 2024
159. SAITO T, Tsuruta H, Iwata J, Kajino A, et al
     Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.
     Int J Cardiol. 2024 Sep 24:132595. doi: 10.1016/j.ijcard.2024.132595.
     PubMed     Abstract available
     
     
     
160. BUONO A, De Biase C, Fabris T, Bellamoli M, et al
     CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry.
     Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569.
     PubMed     Abstract available
     
     
     
161. HARIKRISHNAN S, Koshy L, Ganapathi S, Jeemon P, et al
     Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;411:132273.
     PubMed     Abstract available
     
     
     
162. BANSAL S, Gupta A
     TAVR outcomes in females - What is changing!
     Int J Cardiol. 2024;411:132247.
     PubMed    
     
     
     
163. ABU-MUCH A, Grines CL, Chen S, Batchelor WB, et al
     Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
     Int J Cardiol. 2024;417:132555.
     PubMed     Abstract available
     
     
     
164. PISKLOVA M, Osmak G
     Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
     Int J Cardiol. 2024;410:132220.
     PubMed     Abstract available
     
     
     
165. GOMEZ-HERRERO J, Fernandez-Cordon C, Gonzalez JC, Garcia-Gomez M, et al
     TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes.
     Int J Cardiol. 2024;410:132179.
     PubMed     Abstract available
     
     
     August 2024
166. MARGONATO D
     The therapeutical role of balloon aortic valvuloplasty: Back to the origin?
     Int J Cardiol. 2024 Aug 28:132493. doi: 10.1016/j.ijcard.2024.132493.
     PubMed    
     
     
     
167. BONFIOLI GB, Pagnesi M
     Pulmonary vein flow pattern: A marker of successful repair in primary mitral regurgitation?
     Int J Cardiol. 2024 Aug 28:132498. doi: 10.1016/j.ijcard.2024.132498.
     PubMed    
     
     
     
168. LAI KY, Lee CY, Chang YC, Liu K, et al
     Prognostic value of fully-automated left atrial strain in patients with asymptomatic chronic severe aortic regurgitation.
     Int J Cardiol. 2024 Aug 27:132487. doi: 10.1016/j.ijcard.2024.132487.
     PubMed     Abstract available
     
     
     
169. LIU T, Yang X, Jia R, Han J, et al
     Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
     Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
     PubMed     Abstract available
     
     
     
170. HUANG Z, Lin K, Huang J, Chen Y, et al
     Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2024;409:132213.
     PubMed     Abstract available
     
     
     
171. FAN J, Li Z, Lin D, Miao J, et al
     Long-term outcomes in patients with bicuspid valve stenosis and aortic dilation undergoing transcatheter valve implantation.
     Int J Cardiol. 2024;409:132201.
     PubMed     Abstract available
     
     
     
172. FAGGI A, Denti P
     Contemporary TAVI counterindications and space for staged procedures.
     Int J Cardiol. 2024;409:132172.
     PubMed    
     
     
     
173. NASIR MM, Amir S, Shahid A, Rehman WU, et al
     Valve-in-valve transcatheter mitral valve replacement versus redo-surgical mitral valve replacement for degenerated bioprosthetic mitral valves: A systematic review and meta-analysis.
     Int J Cardiol. 2024;415:132448.
     PubMed     Abstract available
     
     
     
174. AMSALEM I, Carasso S
     Increased utilization of mitral transcatheter edge-to-edge repair in degenerative mitral regurgitation: The essential need for better prognostic and procedural success tools.
     Int J Cardiol. 2024 Aug 14:132457. doi: 10.1016/j.ijcard.2024.132457.
     PubMed    
     
     
     
175. GE Z, Ge Z, Hu C, Wang Y, et al
     Characteristic of myocardial work in mitral valve prolapse with versus without mitral annular disjunction: A propensity-matched study.
     Int J Cardiol. 2024 Aug 6:132434. doi: 10.1016/j.ijcard.2024.132434.
     PubMed     Abstract available
     
     
     
176. YEDIDYA I, Stassen J, Butcher S, van Wijngaarden AL, et al
     The prognostic value of changes in pulmonary vein flow patterns after surgical repair for primary mitral regurgitation.
     Int J Cardiol. 2024;414:132414.
     PubMed     Abstract available
     
     
     
177. YAGI N, Hasegawa H, Kuwajima K, Ogawa M, et al
     Indexed aortic valve area using multimodality imaging for assessing the severity of bicuspid aortic stenosis.
     Int J Cardiol. 2024;414:132416.
     PubMed     Abstract available
     
     
     
178. SPRINGHETTI P, Tomaselli M, Clavel MA
     Measuring the aortic valvular area: Key challenges in aortic stenosis assessment.
     Int J Cardiol. 2024;414:132410.
     PubMed    
     
     
     
179. LORCA R, Salgado M, Alvarez-Velasco R, Reguro JR, et al
     Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
     Int J Cardiol. 2024;408:132117.
     PubMed     Abstract available
     
     
     
180. TONDI L, Pica S, Crimi G, Disabato G, et al
     "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
     Int J Cardiol. 2024;408:132135.
     PubMed     Abstract available
     
     
     
181. BESOLA L, Falcetta G, Ceravolo G, Fiocco A, et al
     New echocardiographic screening tool for left ventricular tract obstruction risk assessment in TMVR.
     Int J Cardiol. 2024;408:132112.
     PubMed     Abstract available
     
     
     July 2024
182. HUSSAIN B, Tarabanis C, Aslam MMS, Dhulipala V, et al
     Inpatient outcomes of mechanical circulatory support devices and heart transplantation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;413:132396.
     PubMed     Abstract available
     
     
     
183. RAHOUMA M, Khairallah S, Lau C, Al Zghari T, et al
     The impact of comorbidities on outcomes of concomitant mitral valve intervention with ascending aortic surgery.
     Int J Cardiol. 2024;413:132398.
     PubMed     Abstract available
     
     
     
184. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
     Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
     Int J Cardiol. 2024;413:132399.
     PubMed     Abstract available
     
     
     
185. TOMSIC A, Holubec T, Sandoval E, Pham T, et al
     Mitral valve repair with resection and non-resection techniques in Barlow's disease: A multi-center study.
     Int J Cardiol. 2024 Jul 22:132387. doi: 10.1016/j.ijcard.2024.132387.
     PubMed     Abstract available
     
     
     
186. DE FELICE F, Musto C, Paolucci L
     TAVR in bicuspid aortic valve and ascending aorta dilatation: sitting on a fence or jumping on the bandwagon.
     Int J Cardiol. 2024 Jul 19:132372. doi: 10.1016/j.ijcard.2024.132372.
     PubMed    
     
     
     
187. AMADOR AF
     Edmonton frail scale in TAVI patients: A new tool for frailty assessment and outcomes prediction.
     Int J Cardiol. 2024;407:132024.
     PubMed    
     
     
     
188. DAYAN V, Fernandez A, Loza G, Parma G, et al
     Early anticoagulation after aortic valve replacement with porcine bioprosthesis randomized control trial(ANTIPRO). 3?years follow-up.
     Int J Cardiol. 2024 Jul 12:132361. doi: 10.1016/j.ijcard.2024.132361.
     PubMed     Abstract available
     
     
     
189. ALBANI S, Merlo M
     Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
     Int J Cardiol. 2024;413:132357.
     PubMed    
     
     
     
190. LOFFI M, Adamo M, Rubbio AP, Pezzola E, et al
     Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jul 8:132317. doi: 10.1016/j.ijcard.2024.132317.
     PubMed     Abstract available
     
     
     
191. FUJIMOTO T, Zen K, Kataoka E, Kitada T, et al
     Balloon aortic valvuloplasty bridge to transcatheter aortic valve replacement is associated with worse in-hospital mortality.
     Int J Cardiol. 2024 Jul 6:132348. doi: 10.1016/j.ijcard.2024.132348.
     PubMed     Abstract available
     
     
     
192. OMAR P, Giovanni B, Williams J, Thomas F, et al
     Quantification of anatomical aortic valve area by multi-detector computed tomography: A pilot 3D-morphological modeling of the stenotic aortic valve.
     Int J Cardiol. 2024 Jul 6:132322. doi: 10.1016/j.ijcard.2024.132322.
     PubMed     Abstract available
     
     
     
193. HEEGER CH, Alagjozovski H
     Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024;412:132299.
     PubMed    
     
     
     
194. BONANNI M, Russo G, De Siati M, Tomao F, et al
     Holographic mixed reality for planning transcatheter aortic valve replacement.
     Int J Cardiol. 2024 Jul 2:132330. doi: 10.1016/j.ijcard.2024.132330.
     PubMed     Abstract available
     
     
     
195. TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
     Ascending aortic dilatation in TAVI: Actor or bystander?
     Int J Cardiol. 2024;406:132089.
     PubMed    
     
     
     June 2024
196. RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
     Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
     Int J Cardiol. 2024;405:131934.
     PubMed     Abstract available
     
     
     
197. LV J, Wu Y, Xu H
     Transcatheter mitral valve intervention in patients with cancer: More efforts are needed.
     Int J Cardiol. 2024 Jun 15:132271. doi: 10.1016/j.ijcard.2024.132271.
     PubMed    
     
     
     
198. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
     Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
     PubMed     Abstract available
     
     
     
199. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Valve-in-valve after transcatheter aortic valve embolization: Do we need to align the commissures?
     Int J Cardiol. 2024 Jun 11:132255. doi: 10.1016/j.ijcard.2024.132255.
     PubMed    
     
     
     
200. D'AMARIO D, Laborante R, Mennuni M, Adamo M, et al
     Efficacy and safety of trans-catheter repair devices for mitral regurgitation: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132245. doi: 10.1016/j.ijcard.2024.132245.
     PubMed     Abstract available
     
     
     
201. AYYAD M, Jabri A, Khalefa BB, Al-Abdouh A, et al
     Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis.
     Int J Cardiol. 2024 Jun 6:132243. doi: 10.1016/j.ijcard.2024.132243.
     PubMed     Abstract available
     
     
     
202. KIRCHNER J, Gercek M, Gesch J, Omran H, et al
     Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair.
     Int J Cardiol. 2024 Jun 5:132233. doi: 10.1016/j.ijcard.2024.132233.
     PubMed     Abstract available
     
     
     
203. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
     Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
     Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
     PubMed     Abstract available
     
     
     
204. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     Response to: Regard to assessing agreement between two raters with kappa statistics.
     Int J Cardiol. 2024;404:131978.
     PubMed    
     
     
     
205. GESKE JB, Schaff HV
     Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
     Int J Cardiol. 2024;404:131961.
     PubMed    
     
     
     
206. ANG SP, Chia JE
     Reevaluating female survival benefit in TAVR: A closer look in the current era.
     Int J Cardiol. 2024;404:131935.
     PubMed    
     
     
     May 2024
207. SHI W, Feng D, Hu X, Wang C, et al
     Prediction of hypoattenuating leaflet thickening in patients underwent transcatheter aortic valves replacement based on clinical factors and 4D-computed tomography morphological characteristics: A retrospective cross-sectional study.
     Int J Cardiol. 2024 May 28:132219. doi: 10.1016/j.ijcard.2024.132219.
     PubMed     Abstract available
     
     
     
208. AURIGEMMA C, Busco M, Bianchini F, Bianchini E, et al
     Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
     Int J Cardiol. 2024 May 28:132218. doi: 10.1016/j.ijcard.2024.132218.
     PubMed     Abstract available
     
     
     
209. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
     Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
     Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
     PubMed     Abstract available
     
     
     
210. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
     Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
     PubMed     Abstract available
     
     
     
211. MARTIN M, Rozado J
     Imaging in severe aortic stenosis: Looking at the future.
     Int J Cardiol. 2024 May 16:132183. doi: 10.1016/j.ijcard.2024.132183.
     PubMed    
     
     
     
212. SEE C, Kim Y, Park J, Wang Y, et al
     High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
     Int J Cardiol. 2024 May 14:132174. doi: 10.1016/j.ijcard.2024.132174.
     PubMed     Abstract available
     
     
     
213. MONDA E, Boccia A, Altobelli I, Mauriello A, et al
     Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
     Int J Cardiol. 2024;408:132067.
     PubMed     Abstract available
     
     
     
214. VOGES I, Hansen JH
     Critical aortic stenosis - The long-term burden.
     Int J Cardiol. 2024;408:132134.
     PubMed    
     
     
     
215. ALPERI A, Pascual I, Moris C, Avanzas P, et al
     Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
     Int J Cardiol. 2024;402:131883.
     PubMed    
     
     
     
216. VESELKA J
     Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
     Int J Cardiol. 2024;402:131842.
     PubMed    
     
     
     
217. GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
     Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
     PubMed     Abstract available
     
     
     April 2024
218. QIU Y, Li M, Song X, Li Z, et al
     Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
     Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
     PubMed     Abstract available
     
     
     
219. LEE CY, Tsai CM, Chiang KC, Huang CC, et al
     Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
     Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
     PubMed     Abstract available
     
     
     
220. CHEN B, Zhang Q
     The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
     PubMed    
     
     
     
221. MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
     Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
     Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
     PubMed     Abstract available
     
     
     
222. GUO Y, Li H, Huang B, Hou L, et al
     LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
     Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
     PubMed    
     
     
     
223. GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
     Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
     Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
     PubMed     Abstract available
     
     
     
224. DAHME T
     Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
     Int J Cardiol. 2024;406:132066.
     PubMed    
     
     
     
225. SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
     Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
     Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
     PubMed    
     
     
     
226. PRAKASH SK
     Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
     Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
     PubMed    
     
     
     
227. CHENG Y, Zhang Q
     Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
     PubMed    
     
     
     
228. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
     Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;400:131790.
     PubMed     Abstract available
     
     
     
229. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
     Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
     Int J Cardiol. 2024;400:131768.
     PubMed     Abstract available
     
     
     March 2024
230. SANG SLW, Weissman C, Parker J, Timek T, et al
     Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
     Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
     PubMed     Abstract available
     
     
     
231. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
     Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
     Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
     PubMed     Abstract available
     
     
     
232. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
     Patterns of aortic valve replacement in Europe and adoption by sex.
     Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
     PubMed     Abstract available
     
     
     
233. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
     Management of prosthetic valve thrombosis with unfractionated heparin.
     Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
     PubMed     Abstract available
     
     
     
234. BICHUETTE LD, Lottenberg MP, Caramelli B
     Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
     Int J Cardiol. 2024;399:131683.
     PubMed    
     
     
     
235. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
     Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;399:131661.
     PubMed     Abstract available
     
     
     
236. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
     Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
     Int J Cardiol. 2024;399:131662.
     PubMed     Abstract available
     
     
     
237. FENG D, Zhao J, Niu G, Zhang Y, et al
     Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
     Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
     PubMed     Abstract available
     
     
     
238. BONELLO B, Issitt R, Hughes M, Carr M, et al
     Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
     Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
     PubMed     Abstract available
     
     
     
239. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
     Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
     Int J Cardiol. 2024;398:131601.
     PubMed     Abstract available
     
     
     
240. LIU Z, Wei P, Jiang H, Zhang F, et al
     Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
     Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
     PubMed    
     
     
     February 2024
241. BOURG C, Lee KC, Donal E
     Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
     Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
     PubMed    
     
     
     
242. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
     Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
     Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
     PubMed     Abstract available
     
     
     
243. AKHTAR KH, Pahuja M, Baber U
     Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
     Int J Cardiol. 2024;397:131619.
     PubMed    
     
     
     
244. DE MARZO V, Zimarino M
     The value of transaxillary access for TAVI.
     Int J Cardiol. 2024;397:131448.
     PubMed    
     
     
     
245. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
     Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
     Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
     PubMed     Abstract available
     
     
     
246. DANDEL M
     It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
     Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
     PubMed    
     
     
     
247. KWAK S, Lee HJ, Lee H, Park JB, et al
     Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
     Int J Cardiol. 2024;396:131574.
     PubMed     Abstract available
     
     
     January 2024
248. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
     Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
     Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
     PubMed     Abstract available
     
     
     
249. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
     ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
     Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
     PubMed     Abstract available
     
     
     
250. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
     Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
     Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
     PubMed     Abstract available
     
     
     
251. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
     Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
     Int J Cardiol. 2024;395:131572.
     PubMed     Abstract available
     
     
     
252. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
     The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
     Int J Cardiol. 2024;395:131416.
     PubMed     Abstract available
     
     
     
253. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
     Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
     Int J Cardiol. 2024;395:131413.
     PubMed    
     
     
     
254. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
     Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
     PubMed     Abstract available
     
     
     
255. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
     Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
     Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
     PubMed     Abstract available
     
     
     
256. LERMAN TT, Levi A, Kornowski R
     Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
     Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
     PubMed    
     
     
     
257. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
     Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
     Int J Cardiol. 2024;394:131353.
     PubMed     Abstract available
     
     
     December 2023
258. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
     Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
     Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
     PubMed     Abstract available
     
     
     
259. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
     Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
     PubMed     Abstract available
     
     
     
260. HIRAM R
     The duration of atrial fibrillation might be associated with right heart disease severity.
     Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
     PubMed    
     
     
     
261. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
     Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
     Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
     PubMed     Abstract available
     
     
     
262. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
     Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
     PubMed     Abstract available
     
     
     
263. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
     Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
     Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
     PubMed     Abstract available
     
     
     
264. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
     Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
     Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
     PubMed     Abstract available
     
     
     
265. BOLETI OD, Roussos S, Norrish G, Field E, et al
     Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
     Int J Cardiol. 2023;393:131405.
     PubMed     Abstract available
     
     
     
266. MORONI A, Tondi L, Milani V, Pieroni M, et al
     Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
     Int J Cardiol. 2023;393:131357.
     PubMed     Abstract available
     
     
     
267. OZLEK B
     Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
     Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
     PubMed    
     
     
     
268. GOZDEK M, Kowalewski M
     Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
     Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
     PubMed    
     
     
     
269. SEE C, Wang Y, Yang Y, Tirziu D, et al
     Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
     Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
     PubMed     Abstract available
     
     
     
270. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
     Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
     Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
     PubMed     Abstract available
     
     
     
271. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
     Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
     Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
     PubMed     Abstract available
     
     
     
272. DORIAN D, Scolari FL, Habib M, Brahmbhatt DH, et al
     Association of duration and intensity of exercise with phenotypic expression in hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;392:131253.
     PubMed     Abstract available
     
     
     November 2023
273. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
     Unmasking tricuspid regurgitation.
     Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
     PubMed    
     
     
     
274. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
     Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
     Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
     PubMed     Abstract available
     
     
     
275. CHAN J, Narayan P, Fudulu DP, Dong T, et al
     Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
     Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
     PubMed     Abstract available
     
     
     
276. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
     The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
     Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
     PubMed     Abstract available
     
     
     
277. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
     About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
     PubMed     Abstract available
     
     
     
278. HU D, Lan T, Chen Y, Chen L, et al
     An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
     Int J Cardiol. 2023;391:131286.
     PubMed     Abstract available
     
     
     
279. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
     Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
     Int J Cardiol. 2023;391:131265.
     PubMed     Abstract available
     
     
     
280. WU Z, Nie C, Zhu C, Meng Y, et al
     Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
     Int J Cardiol. 2023;391:131266.
     PubMed     Abstract available
     
     
     
281. DE SARRO R, Sabatino J
     Left atrial function's evaluation in aortic stenosis: A clinical imperative.
     Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
     PubMed    
     
     
     
282. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
     Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
     Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
     PubMed     Abstract available
     
     
     
283. ZHOU N, Liu A, Weng H, Liu W, et al
     Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
     Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
     PubMed     Abstract available
     
     
     
284. DORES H, Toste A, Cardim N
     Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
     Int J Cardiol. 2023;390:131260.
     PubMed     Abstract available
     
     
     
285. SALA A, Alfieri O
     Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
     Int J Cardiol. 2023;390:131146.
     PubMed    
     
     
     
286. NEMES A
     Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
     Int J Cardiol. 2023;390:131170.
     PubMed    
     
     
     October 2023
287. BRANDES A
     Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
     Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
     PubMed    
     
     
     
288. LIU Z, Wei P, Jiang H, Zhang F, et al
     Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
     Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
     PubMed     Abstract available
     
     
     
289. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
     Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
     PubMed     Abstract available
     
     
     
290. HOU Q, Wu W, Fang L, Zhang X, et al
     Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
     Int J Cardiol. 2023;389:131263.
     PubMed     Abstract available
     
     
     
291. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
     Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
     Int J Cardiol. 2023;389:131194.
     PubMed     Abstract available
     
     
     
292. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
     Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
     Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
     PubMed     Abstract available
     
     
     
293. BHOGAL S, Waksman R, Shea C, Zhang C, et al
     Self-expanding and balloon-expandable valves in low risk TAVR patients.
     Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
     PubMed     Abstract available
     
     
     
294. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
     Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
     Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
     PubMed     Abstract available
     
     
     
295. CHEN X
     The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;388:131172.
     PubMed    
     
     
     
296. MARTIN M, Moris C
     Subclinical leaflet thrombosis after TAVI: To be or not to be.
     Int J Cardiol. 2023;388:131140.
     PubMed    
     
     
     September 2023
297. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
     Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
     Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
     PubMed     Abstract available
     
     
     
298. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
     Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
     Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
     PubMed     Abstract available
     
     
     
299. CHANG WT, Lin CH, Lee WC, Kan WC, et al
     Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
     Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
     PubMed     Abstract available
     
     
     
300. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
     Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
     Int J Cardiol. 2023;387:131099.
     PubMed     Abstract available
     
     
     
301. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
     Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
     Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
     PubMed     Abstract available
     
     
     
302. LEOW R, Kong WKF, Li TY, Poh KK, et al
     Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
     Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
     PubMed     Abstract available
     
     
     
303. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
     Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
     Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
     PubMed     Abstract available
     
     
     
304. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
     Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
     Int J Cardiol. 2023;386:17-23.
     PubMed     Abstract available
     
     
     August 2023
305. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
     Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
     Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
     PubMed     Abstract available
     
     
     
306. LI S, Fang L, Wu W, Zhang Z, et al
     Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
     Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
     PubMed     Abstract available
     
     
     
307. PIERONI M, Ciabatti M, Bolognese L
     Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
     Int J Cardiol. 2023;385:41-42.
     PubMed    
     
     
     
308. NEMES A
     The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
     Int J Cardiol. 2023;385:22.
     PubMed    
     
     
     July 2023
309. SISINNI A, Estevez-Loureiro R
     The K-clip: Time for a new tricuspid valve focal annuloplasty system.
     Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
     PubMed    
     
     
     
310. BARKI M, Ielasi A, Buono A, Maffeo D, et al
     Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
     Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
     PubMed     Abstract available
     
     
     
311. SANCHIS L, Farrero M
     Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
     Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
     PubMed    
     
     
     
312. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
     Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
     Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
     PubMed     Abstract available
     
     
     
313. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
     Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
     Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
     PubMed     Abstract available
     
     
     
314. ZHANG X, Jin Q, Pan W, Li W, et al
     First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
     Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
     PubMed     Abstract available
     
     
     
315. CHATTERJEE A, Kazui T, Acharya D
     Growing prevalence of aortic stenosis - Question of age or better recognition?
     Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
     PubMed    
     
     
     
316. XU Z, Dai XF, Lin F, Chen LW, et al
     Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
     Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
     PubMed     Abstract available
     
     
     
317. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
     How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
     Int J Cardiol. 2023;382:64-67.
     PubMed     Abstract available
     
     
     
318. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
     Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
     Int J Cardiol. 2023;382:12-19.
     PubMed     Abstract available
     
     
     June 2023
319. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
     The long-term clinical course of moderate tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
     PubMed     Abstract available
     
     
     
320. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
     Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
     Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
     PubMed     Abstract available
     
     
     
321. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
     2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
     Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
     PubMed     Abstract available
     
     
     
322. LEE M, Shechter A, Han D, Nguyen LC, et al
     Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
     Int J Cardiol. 2023;381:62-69.
     PubMed     Abstract available
     
     
     
323. BOURG C, Curtis E, Donal E
     Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
     PubMed    
     
     
     
324. RAHIMI M, Kpodonu J
     Myectomy or myomectomy, that is the question.
     Int J Cardiol. 2023;380:28.
     PubMed    
     
     
     
325. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
     Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
     Int J Cardiol. 2023;380:65-71.
     PubMed     Abstract available
     
     
     May 2023
326. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
     Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
     Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
     PubMed     Abstract available
     
     
     
327. ZHOU Y, Lin X, Zhu Q, Li H, et al
     Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
     Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
     PubMed     Abstract available
     
     
     
328. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
     Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
     PubMed     Abstract available
     
     
     
329. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
     Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
     PubMed     Abstract available
     
     
     April 2023
330. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
     Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
     Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
     PubMed     Abstract available
     
     
     
331. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
     Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
     Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
     PubMed     Abstract available
     
     
     
332. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
     Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
     Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
     PubMed     Abstract available
     
     
     
333. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
     Factors associated with the progression of aortic valve calcification in older adults.
     Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
     PubMed     Abstract available
     
     
     
334. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
     Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
     Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
     PubMed     Abstract available
     
     
     
335. MERLO M, Folgheraiter A, Sinagra G
     Evolving mortality and clinical scenarios in HCM: Where are we?
     Int J Cardiol. 2023;376:97-99.
     PubMed    
     
     
     March 2023
336. MENG H, Zhao X, Wang JD, Wan LY, et al
     Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
     Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
     PubMed     Abstract available
     
     
     
337. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
     Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
     Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
     PubMed     Abstract available
     
     
     
338. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
     The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
     Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
     PubMed     Abstract available
     
     
     
339. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
     Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
     Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
     PubMed     Abstract available
     
     
     February 2023
340. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
     Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
     Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
     PubMed     Abstract available
     
     
     
341. MALTES S, Abecasis J, Santos RR, Lopes P, et al
     LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
     Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum